Andere Sprachen Ajanta Pharma Limited Bombay S.E.

Aktien

A14QQH

INE031B01049

AJANTPHARM

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:01:20 04.06.2024			% 5 Tage	% 1. Jan.
2 294 ^INR	-1,12 %		-5,19 %	+10,03 %

03.05.	INDIA STOCKS-India's Nifty 50 rutscht von Rekordhoch ab, da IT-Aktien belasten	RE
02.05.	Ajanta Pharma's konsolidierter Gewinn verdoppelt sich fast im vierten Quartal des Geschäftsjahres	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	03.05.
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	02.05.
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02.05.
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02.05.
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.	02.05.
Ajanta Pharma Limited Provides Revenue Guidance for the Fiscal Year 2025	02.05.
Ajanta Pharma Limited authorizes a Buyback Plan.	02.05.
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	26.04.
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02.02.
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	31.01.
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31.01.
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	25.01.
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31.10.23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31.10.23
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31.08.23
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30.08.23
Ajanta Pharma Logs Increase in Fiscal Q1 Consolidated Profit	28.07.23
Ajanta Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27.07.23
Ajanta Pharma Board to Consider Interim Dividend for Fiscal 2024	24.07.23
Ajanta Pharma Limited Confirms the Interim Dividend for the Year Ended 31 March 2023	18.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ajanta Pharma Limited Bombay S.E.

Aktien

A14QQH

INE031B01049

AJANTPHARM

Andere Sprachen

Filter